Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-576-1 | CAS number: 3148-73-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2004-03-08 to 2004-03-23 (experimental phase)
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The study is a screening study which did not formally follow a guideline method, and was not formally performed under audited GLP, however, the laboratory facilities were operated according to GLP. The purity of the test material was not reported. The documentation in the report was very limited. Although the results are considered valid, the screening study itself cannot be considered formally reliable due to the lack of formal guideline, quality assurance, and very limited documentation.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Remarks:
- relevant deviations from SOP specifications were not reported
- Principles of method if other than guideline:
- The study was performed according to the internal standard operational procedure 595.12 of the laboratory, but no details on this SOP are given in the report. The principles of the internal SOP are to the greatest extent similar to those described in OECD Testing Guideline No. 429 (Mouse Local Lymph Node Assay).
- GLP compliance:
- no
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/Ca
- Sex:
- not specified
- Details on test animals and environmental conditions:
- not reported
- Vehicle:
- dimethyl sulphoxide
- Concentration:
- 2.5, 5 and 10% w/w
- No. of animals per dose:
- four animals
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: not reported
- Irritation: not reported
- Lymph node proliferation response: not reported
- Other responses: clinical observations, body weight change, mortality
MAIN STUDY
- Criteria used to consider a positive response: stimulation index
- Vehicle control: four animals treated with dimethyl sulphoxide
TREATMENT PREPARATION AND ADMINISTRATION:
- Vehicle: dimethyl sulphoxide
- Application/site: topical on the dorsal surface of ears
- Application volumes: 25 µL per ear - Statistics:
- not reported
- Positive control results:
- no positive control tested
- Parameter:
- SI
- Remarks on result:
- other: Vehicle: not applicable 2.5% w/w in dimethyl sulphoxide: 1.01 5% w/w in dimethyl sulphoxide: 1.43 10% w/w in dimethyl sulphoxide: 0.78
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Vehicle: 7571.75 DPM, 946.47 DPM/Node 2.5% w/w in dimethyl sulphoxide: 7665.04 DPM, 958.13 DPM/Node 5% w/w in dimethyl sulphoxide: 10815.94 DPM, 1351.99 DPM/Node 10% w/w in dimethyl sulphoxide: 5933.59 DPM, 741.70 DPM/Node
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was considered as a non-sensitiser under the conditions of the Mouse Local Lymph Node Assay. Although the result is considered to be valid, due to the lack of formal guideline and quality assurance, and very limited documentation, it must be regarded as not being reliable.
- Executive summary:
The potential for skin sensitisation of the test substance was investigated in a non-GLP mouse local lymph node assay in CBA/Ca mice that was conducted according to principles similar to those given in OECD Testing Guideline No. 429. Following a preliminary sighting test at which there were no deaths or signs of systemic toxicity at a concentration of 10% w/w, three groups, each of four animals, were treated with 50 µL of the test material (25 µL per ear) as a solution in dimethyl sulphoxide at concentrations of 2.5%, 5% and 10% w/w. A further group of four animals was treated with dimethyl sulphoxide alone. The Stimulation Indeces expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle group were 1.01, 1.43 and 0.78 for the groups treated with concentrations of 2.5, 5 and 10% w/w, respectively and hence below the threshold of 3.0 indicating a positive result.
Reference
No signs of systemic toxicity or body weight changes and no mortality were observed in the screening test applying a solution of the test substance in dimethyl sulphoxide at a concentration of 10% w/w to the skin surface of the ears.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Skin
Only one study addressing skin sensitisation is available (Pooles 2004f). The test was comparable to OECD TG 429. The test substance was tested under the conditions of the Mouse Local Lymph Node Assay. The study is considered to be relevant. It is regarded as adequate for classification and labelling, but not reliable. Following a preliminary sighting test at which there were no deaths or signs of systemic toxicity at a concentration of 10% w/w, three groups, each of four animals, were treated with 50 µL of the test material (25 µL per ear) as a solution in dimethyl sulphoxide at concentrations of 2.5%, 5% and 10% w/w. A further group of four animals was treated with dimethyl sulphoxide alone. The Stimulation Indices expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle group were 1.01, 1.43 and 0.78 for the groups treated with concentrations of 2.5, 5 and 10% w/w, respectively and hence below the positive result threshold of 3.0.
Inhalation
No study available on respiratory sensitisation.
Short description of key information:
- Skin: not sensitising, mouse, similar to OECD 429, Pooles 2004
Justification for selection of skin sensitisation endpoint:
Only study available.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Additional information:
No information on respiratory sensitisation is available.
Short description of key information:
No information on respiratory sensitisation is available.
Justification for classification or non-classification
Skinsensitisation
The substance showed no potential for skin sensitisation in a mouse LLNA test. Therefore no classification is needed for this endpoint according to commission Directive 2001/59/EC. The classification is not considered conclusive due to the reliability of the study.
The substance showed no potential for skin sensitisation in a mouse LLNA test. Therefore no classification is needed for this endpoint according to Regulation (EC) No. 1272/2006, Part 3, 3.2. The classification is not considered conclusive due to the reliability of the study.
Respiratory sensitisation
As no studies are available for this endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.